Wolf Reik obtained his MD from the University of Hamburg. He did his thesis work with Rudolf Jaenisch, and postdoctoral work with Azim Surani in Cambridge. He was a Fellow of the Lister Â鶹ÊÓƵ of Preventive Medicine at Cambridge and the Â鶹ÊÓƵ’s Associate Director (2004-2020) and Head of the Epigenetics Programme (2008-2020). From May 2020 – July 2021 he held the position of Acting Director and then Director for the Â鶹ÊÓƵ.
Wolf became the Director of Altos Labs Cambridge Â鶹ÊÓƵ on 1st March 2022 and maintains strong links with the Babraham Â鶹ÊÓƵ as an honorary group leader. He is honorary Professor of Epigenetics at the University of Cambridge, Associate Faculty at the Wellcome Sanger Â鶹ÊÓƵ, Affiliate Faculty at the Stem Cell Â鶹ÊÓƵ and a member of the Centre for Trophoblast Research.
His research interests are in mammalian epigenetics, particularly in epigenetic reprogramming during mammalian development and its role in stem cell biology, inheritance and ageing. He has published more than 250 research articles with an h-index of 122. He won the Wellcome Prize in Physiology and is a member of EMBO and the Academia Europaea, and a Fellow of the Academy of Medical Sciences and the Royal Society.